SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

Skin & hair

Seborrheic Keratosis vs. Melanoma: How to Tell the Difference

Seborrheic keratoses are common, harmless growths with a waxy, 'stuck-on' appearance, while melanoma is a serious skin cancer that can also appear as a dark or multicolored spot. Because the two can occasionally look alike even to experienced clinicians, any spot that is changing, bleeding, or worrying deserves a professional skin exam.

Talk to a clinician

Nina Osei, NPNurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

What does a seborrheic keratosis typically look and feel like?

Seborrheic keratoses (SK) are benign overgrowths of the outermost skin layer. They are not contagious, not precancerous, and not caused by sun exposure, though sun-exposed areas are common locations. They tend to appear after age 30 and become more numerous with age.

The classic appearance is a waxy, slightly raised patch with a sharp, well-defined border and a 'stuck-on' or 'pasted-on' quality — as though it could be peeled off (though attempting this is not advisable). Color is usually uniform, ranging from light tan to deep brown or even black. The surface is often rough or warty, sometimes with tiny pits. They can appear anywhere except the palms and soles.

Having many seborrheic keratoses is common and is not in itself a sign of illness.

What sets melanoma apart — the ABCDE guide

Dermatologists use the ABCDE framework as a practical screen for concerning lesions 12:

  • A — Asymmetry: One half does not match the other
  • B — Border: Edges are ragged, notched, or blurred rather than smooth and sharp
  • C — Color: More than one color within the same lesion — shades of brown, black, red, white, or blue
  • D — Diameter: Larger than roughly 6 mm (about the width of a pencil eraser), though melanomas can be smaller
  • E — Evolution: The lesion has changed in size, shape, or color, or has started bleeding or itching

None of these criteria is perfect on its own. Some melanomas look deceptively ordinary, and some seborrheic keratoses can mimic melanoma closely enough that even dermatologists use dermoscopy to be certain. An additional practical concept is the 'ugly duckling' — a lesion that simply looks noticeably different from all your other spots is worth having evaluated 1.

When do the two look so similar that only a clinician can tell?

A dark, irregularly pigmented seborrheic keratosis and an early thin melanoma can be nearly impossible to distinguish by the naked eye alone. This is not a failure of common sense — it is a recognized diagnostic challenge with a well-established solution 2.

Dermoscopy is a handheld instrument that illuminates and magnifies the skin surface, revealing structural patterns not visible to the naked eye. It substantially improves diagnostic accuracy. When doubt remains after dermoscopy, a biopsy — removing all or part of the lesion for microscopic analysis — is definitive. A biopsy is a minor outpatient procedure and the only way to be certain of a diagnosis.

Are there other dark or growing spots that get confused with these two?

Several other growths enter the differential:

  • Pigmented basal cell carcinoma — a type of skin cancer that can appear as a dark spot with a pearly or translucent border; usually on sun-exposed areas of the face
  • Dermatofibroma — a firm brownish bump, most common on the legs, that dimples inward when pinched; benign
  • Dysplastic (atypical) nevus — a mole with irregular features and uneven pigment; benign but warrants monitoring

A clinician familiar with skin lesions can guide next steps for any of these.

What is the sign of Leser-Trélat and does it matter?

A sudden crop of many new seborrheic keratoses appearing over a short period has been called the sign of Leser-Trélat, which some case reports have linked to internal cancers. This is a rare association, the evidence is based largely on case reports rather than robust studies, and it should not cause alarm when seborrheic keratoses accumulate gradually over years — which is the normal pattern. However, a rapid new crop appearing over weeks is worth mentioning to a clinician.

What happens at a dermatology skin check?

A dermatologist or trained primary care provider performs a full-body or targeted skin exam, typically using dermoscopy. Many seborrheic keratoses can be identified confidently on the spot. If a lesion is uncertain, the next step is a biopsy — usually a shave or punch removal done under local anesthetic in the office, with results returning within one to two weeks 3.

Seborrheic keratoses that catch on clothing or are cosmetically bothersome can be removed by cryotherapy, shave excision, or laser — these methods are not medically necessary for a confirmed SK, but they are options to discuss.

For people with a personal or family history of melanoma, or with many atypical moles, total body photography provides a baseline that lets clinicians track changes over time with precision.

Common questions

Can a photo app or AI tool reliably distinguish seborrheic keratosis from melanoma?

Consumer photo tools are not a reliable substitute for a clinical exam with dermoscopy. Even experienced dermatologists with specialized instruments can find these two difficult to tell apart. If a spot is concerning you, an in-person exam is the appropriate step.

Do seborrheic keratoses ever become cancerous?

Seborrheic keratoses are benign and do not become malignant. However, a melanoma can occasionally arise within or adjacent to a seborrheic keratosis, making evaluation of any changing or atypical-looking SK worthwhile.

How often should I have a skin check if I have many moles or a family history of melanoma?

This depends on your personal and family history, skin type, and prior biopsy results. A dermatologist can recommend a monitoring frequency tailored to your situation — typically anywhere from every 6 to 12 months for higher-risk individuals.

Is skin cancer screening routinely recommended for everyone?

The US Preventive Services Task Force currently concludes there is insufficient evidence to recommend routine full-body skin cancer screening for the general adult population [4]. This does not mean skin checks have no value — clinicians individualize recommendations based on personal risk factors, and people with a history of skin cancer or significant sun exposure are often monitored more closely.

Talk to a clinician

Nina Osei, NPNurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

Signs a skin spot warrants prompt evaluation

  • A spot that is growing rapidly over weeks rather than slowly over years
  • Irregular, ragged, or notched borders
  • Multiple colors within one lesion — mixtures of black, brown, red, white, or blue
  • Bleeding, oozing, or crusting that will not heal
  • Itching, pain, or tenderness in the lesion
  • A new dark streak appearing under a fingernail or toenail
  • A mole or spot that looks very different from all your other moles — the 'ugly duckling'

This article is general health information and is not a diagnosis. Only a licensed clinician who examines you in person can tell you what a skin lesion is. If you are concerned about any spot on your skin, see a dermatologist or trained provider.

References

  1. 1.AAD Ad Hoc Task Force for the ABCDEs of Melanoma; Tsao H, Olazagasti JM, Cordoro KM, et al. (2015). Early detection of melanoma: reviewing the ABCDEs. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2015.01.025ABCDE framework for melanoma screening including the 'ugly duckling' sign
  2. 2.Duarte AF, Sousa-Pinto B, Azevedo LF, Barros AM, Puig S, Malvehy J, Haneke E, Correia O (2021). Clinical ABCDE rule for early melanoma detection. European Journal of Dermatology. doi:10.1684/ejd.2021.4171Clinical utility and limitations of the ABCDE rule; diagnostic challenge of distinguishing seborrheic keratosis from melanoma
  3. 3.Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, et al. (2019). Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2018.08.055Biopsy as the definitive diagnostic step for uncertain pigmented lesions; dermoscopy role in evaluation
  4. 4.US Preventive Services Task Force (2023). Skin Cancer: Screening (Final Recommendation Statement). JAMA / USPSTF. doi:10.1001/jama.2023.4342USPSTF conclusion that current evidence is insufficient to recommend routine full-body skin cancer screening for the general adult population

4 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.